Article info
PDFBrief report
Endangerment of the iPSC stock project in Japan: on the ethics of public funding policies
- Correspondence to Dr Akira Akabayashi, Department of Biomedical Ethics, School of Public Health, University of Tokyo Graduate School of Medicine, Tokyo 113-0033, Japan; akirasan-tky{at}umin.ac.jp
Citation
Endangerment of the iPSC stock project in Japan: on the ethics of public funding policies
Publication history
- Received June 20, 2018
- Accepted July 13, 2018
- First published August 7, 2018.
Online issue publication
September 25, 2018
Article Versions
- Previous version (7 August 2018).
- Previous version (3 September 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Other content recommended for you
- What are considered ‘good facts’?
- A rebuttal to Akabayashi and colleagues’ criticisms of the iPSC stock project
- Embryo as epiphenomenon: some cultural, social and economic forces driving the stem cell debate
- Is a consensus possible on stem cell research? Moral and political obstacles
- Organoids as hybrids: ethical implications for the exchange of human tissues
- The moral value of induced pluripotent stem cells: a Japanese bioethics perspective on human embryo research
- Clinical applications of patient-specific induced pluripotent stem cells in cardiovascular medicine
- US public investment in development of mRNA covid-19 vaccines: retrospective cohort study
- Conflicting messages concerning current strategies against research misconduct in Japan: a call for ethical spontaneity
- Tobacco control funding for low-income and middle-income countries in a time of economic hardship